Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 14 | 2024 | 1862 | 1.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2024 | 34 | 1.080 |
Why?
|
| Pre-Eclampsia | 2 | 2023 | 56 | 1.020 |
Why?
|
| Anticoagulants | 2 | 2024 | 57 | 0.940 |
Why?
|
| Heart Valve Prosthesis | 1 | 2024 | 9 | 0.930 |
Why?
|
| Patient Safety | 1 | 2024 | 9 | 0.930 |
Why?
|
| Warfarin | 1 | 2024 | 19 | 0.920 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 29 | 0.920 |
Why?
|
| Maternal Mortality | 1 | 2024 | 58 | 0.910 |
Why?
|
| Family | 1 | 2023 | 35 | 0.850 |
Why?
|
| Congenital Abnormalities | 1 | 2023 | 7 | 0.840 |
Why?
|
| Neural Tube Defects | 1 | 2023 | 6 | 0.840 |
Why?
|
| Pregnant Women | 2 | 2022 | 89 | 0.830 |
Why?
|
| Female | 16 | 2024 | 9103 | 0.830 |
Why?
|
| Retrospective Studies | 7 | 2024 | 799 | 0.830 |
Why?
|
| Asphyxia Neonatorum | 1 | 2023 | 11 | 0.820 |
Why?
|
| Semen | 1 | 2022 | 3 | 0.820 |
Why?
|
| Abortion, Habitual | 1 | 2022 | 4 | 0.820 |
Why?
|
| Brain Diseases | 1 | 2023 | 24 | 0.810 |
Why?
|
| Developing Countries | 2 | 2024 | 400 | 0.810 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 280 | 0.780 |
Why?
|
| Humans | 16 | 2024 | 14537 | 0.660 |
Why?
|
| Premature Birth | 3 | 2023 | 80 | 0.550 |
Why?
|
| Tertiary Care Centers | 3 | 2024 | 80 | 0.470 |
Why?
|
| Infant | 5 | 2023 | 2244 | 0.460 |
Why?
|
| Infant, Newborn | 6 | 2023 | 1479 | 0.440 |
Why?
|
| Pregnancy Complications | 2 | 2024 | 55 | 0.440 |
Why?
|
| South Africa | 8 | 2024 | 7596 | 0.440 |
Why?
|
| Pregnancy Outcome | 5 | 2024 | 117 | 0.410 |
Why?
|
| Young Adult | 2 | 2024 | 2498 | 0.290 |
Why?
|
| Adult | 3 | 2024 | 5913 | 0.240 |
Why?
|
| Bioprosthesis | 1 | 2024 | 8 | 0.230 |
Why?
|
| Medical Errors | 1 | 2024 | 1 | 0.230 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 7 | 0.230 |
Why?
|
| Gynecology | 1 | 2024 | 3 | 0.230 |
Why?
|
| Genital Neoplasms, Female | 1 | 2024 | 3 | 0.230 |
Why?
|
| Abortion, Spontaneous | 1 | 2024 | 15 | 0.230 |
Why?
|
| Enoxaparin | 1 | 2024 | 14 | 0.230 |
Why?
|
| Maternal Health Services | 1 | 2024 | 52 | 0.230 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 30 | 0.230 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 20 | 0.230 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 42 | 0.220 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2023 | 4 | 0.220 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 353 | 0.220 |
Why?
|
| Liver Transplantation | 1 | 2024 | 55 | 0.220 |
Why?
|
| Cause of Death | 1 | 2024 | 221 | 0.210 |
Why?
|
| Asphyxia | 1 | 2023 | 5 | 0.210 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 22 | 0.210 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 5 | 0.210 |
Why?
|
| Placenta | 1 | 2023 | 44 | 0.200 |
Why?
|
| Uterus | 1 | 2022 | 20 | 0.200 |
Why?
|
| Cerclage, Cervical | 1 | 2022 | 1 | 0.200 |
Why?
|
| Hypertension | 2 | 2024 | 419 | 0.200 |
Why?
|
| Incidence | 1 | 2024 | 685 | 0.200 |
Why?
|
| Perinatal Death | 1 | 2022 | 33 | 0.190 |
Why?
|
| Cesarean Section | 1 | 2022 | 87 | 0.190 |
Why?
|
| Prenatal Care | 1 | 2023 | 147 | 0.190 |
Why?
|
| Hospitalization | 1 | 2024 | 418 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 8 | 0.180 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 12 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 27 | 0.180 |
Why?
|
| Middle Aged | 2 | 2024 | 3601 | 0.160 |
Why?
|
| Prevalence | 1 | 2023 | 1192 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 529 | 0.130 |
Why?
|
| Male | 1 | 2022 | 6754 | 0.090 |
Why?
|
| HIV Infections | 2 | 2024 | 5097 | 0.070 |
Why?
|
| Graft Survival | 1 | 2024 | 40 | 0.060 |
Why?
|
| Bangladesh | 1 | 2023 | 17 | 0.050 |
Why?
|
| Comorbidity | 1 | 2024 | 188 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 64 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 54 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 77 | 0.050 |
Why?
|
| Research Design | 1 | 2023 | 124 | 0.050 |
Why?
|
| Parturition | 1 | 2022 | 31 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 177 | 0.050 |
Why?
|
| Aged | 1 | 2024 | 1740 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 480 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 967 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 472 | 0.040 |
Why?
|
| Risk Factors | 1 | 2021 | 1475 | 0.030 |
Why?
|